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entinel surveillance of pandemic inﬂuenza A H1N1 in
enya in the period August — November 2009
. Achilla ∗, J. Majanja, M. Wadegu, W. Bulimo, D. Schnabel
USAMRU-K, Nairobi, Kenya
Background: In April 2009 a new variant of Inﬂuenza virus
hat was later declared a pandemic strain by the World
ealth Organization appeared on the American continent.
he ﬁrst case of the pandemic Inﬂuenza A H1N1 (pH1N1) in
enya was detected on 29th June 2009. The ﬁrst sentinel
urveillance case appeared in August 2009 and since then
ncreasing numbers of pH1N1 have been detected within the
egular sentinel surveillance network.
Methods: Eight public hospitals distributed across and
epresenting the entire country comprise our sentinel
urveillance sites. Nasopharyngeal swab specimens are col-
ected within 72 hours of symptom onset from consenting
atients presenting with inﬂuenza like illness. Specimens
re transported in liquid nitrogen to the National Inﬂuenza
enter. For all patient specimens, RNA is extracted followed
y reverse transcription and real time PCR assays. The spe-
iﬁc assays include screening for seasonal inﬂuenza A and B.
ll samples positive for Inﬂuenza A are further subtyped for
easonal H1, Seasonal H3 and pandemic H1.Results: In the four months from August to November,
total of 1329 samples were screened from the sentinel
urveillance network. Out of these 160 samples represent-
ng 12% were positive for pH1N1. Of these, 83(51.8%) were
t
c
r
lternational Congress on Infectious Diseases (ICID) Abstracts
rom males and 120 (75%) of the patients were aged 5 years
nd below. The ages of the positive cases ranged from 9
onths to 53 years. No deaths were recorded in the coun-
ry during that period. 55% of the cases were found in the
estern region, 18% in the central region and 27% in the
astern/Coastal region. The epicenter of the outbreak was
n the Western region and this is reﬂected in the higher
ercentages of cases from that region. The Eastern/Coastal
egion receives many tourists from outside Africa and this
lso is reﬂected in the high percentages of cases reported
ere.
Conclusion: These results indicate that within a few
onths of introduction into Kenya, the pH1N1 quickly spread
hroughout the country. Most of the cases were seen among
hildren less than ﬁve years of age. The results show that
ender was not a risk factor in contracting the virus in Kenya.
oi:10.1016/j.ijid.2010.02.2120
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holerae in the Americas region: An eradicated problem?
. Ramon-Pardo1,∗, G. de Cosio1, M. Tato2, J. Mckenney1
Pan American Health Organization, Washington, DC, USA
Hospital Ramón y Cajal, Madrid, Spain
Background: The Pan American Health Organization
PAHO) proposed, in 1996, monitoring of resistance to
ntibiotics in the Americas Region. Thus organizing the
urveillance and Monitoring Network of Antimicrobial Resis-
ances countries committed to compiling information on
he identiﬁcation of isolated species and their sensitivity
o antibiotics. The protocols of surveillance used within the
etwork are consistent with the recommendations of WHO
or diarrheal diseases and respiratory tract infections. As
athogen responsible for severe disease and serious impact
n public health, Vibrio cholerae from human isolates has
een included among the surveyed pathogens. This study
ims at describing the capacity of the Network for detect-
ng V. cholerae outbreaks, by geographic distribution and
he trends of resistance to antibiotics.
Methods: Information about the serogroups and antimi-
robial susceptibility patterns of V. cholerae isolates were
nnually sent to the Network by the countries. Period of
tudy: 2000-2007. V. cholerae were identiﬁed by standard
aboratory methods. Serotype characterization was per-
ormed by serologic test (slide agglutination technique with
olyvalent antisera). Susceptibility to antimicrobial agents
as determined by the Kirby-Bauer disk diffusion method
nd interpreted ace recommended by the Clinical Labora-
ory Standards Institute.
Results: The total number of V. cholerae human isolates
otiﬁed during the study period was 2095. V. cholerae iso-
ates were only reported from Brazil, Cuba, El Salvador,
exico and Peru. V. cholerae serogroups O1 and non-O1
onstituted 179 (8.5%) and 1561 (74.5%) isolates, respec-
ively. During 2000, 2001 and 2002, 355 (17%) isolates were
otiﬁed without serotype characterization. Since 2003 all
he isolates were reported with the corresponding serotype
haracterization. For V. cholerae serogroup non-O1, the
esistance to ciproﬂoxacin and clorafenicol has remained
ow throughout these years. Nevertheless, the resistance
